Antibody-Enhanced, Fc Gamma Receptor-Mediated Endocytosis of Clostridium difficile Toxin A

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Infection and Immunity

• Publication date

  2009-03-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.01577-08PMID 19307220PMCID PMC2687358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages.

  2009cited by this paper
• gp96 Is a Human Colonocyte Plasma Membrane Binding Protein for Clostridium difficile Toxin A

  2008cited by this paper
• Structure and mode of action of clostridial glucosylating toxins: the ABCD model.

  2008cited by this paper
• BMC Microbiology BioMed Central Methodology article Detection of Balamuthia mandrillaris DNA by real-time PCR

  2008cited by this paper
• Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells.

  2008cited by this paper
• Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease.

  2007influential reference
• Autocatalytic cleavage of Clostridium difficile toxin B

  2007cited by this paper
• Neutralized Adenovirus-Immune Complexes Can Mediate Effective Gene Transfer via an Fc Receptor-Dependent Infection Pathway

  2006cited by this paper
• Cholesterol-dependent Pore Formation of Clostridium difficile Toxin A*

  2006cited by this paper
• Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile-Induced Mortality in Hamsters

  2006cited by this paper
• Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication

  2006cited by this paper
• Cellular stability of Rho‐GTPases glucosylated by Clostridium difficile toxin B

  2006cited by this paper
• Differential kinase requirements in human and mouse Fc‐gamma receptor phagocytosis and endocytosis

  2006cited by this paper
• Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea.

  2005cited by this paper
• An epidemic, toxin gene-variant strain of Clostridium difficile.

  2005cited by this paper
• Clostridium difficile Toxins: Mechanism of Action and Role in Disease

  2005cited by this paper
• Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells.

  2005cited by this paper
• A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

  2005cited by this paper
• Production and Characterization of Monoclonal Antibodies against Enterocytozoon bieneusi Purified from Rhesus Macaques

  2005cited by this paper
• Clostridium difficile and acute respiratory distress syndrome.

  2004cited by this paper
• Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages

  2004cited by this paper
• Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.

  2003cited by this paper
• Cellular Uptake of Clostridium difficile Toxin B

  2003cited by this paper
• Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications

  2003cited by this paper
• Fc receptor biology.

  2003cited by this paper
• Clostridium difficile colitis causing toxic megacolon, severe sepsis and multiple organ dysfunction syndrome

  2003cited by this paper
• Clinical practice. Antibiotic-associated diarrhea.

  2002cited by this paper
• Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

  2002cited by this paper
• Liver Abscess Caused by Clostridium difficile

  2001cited by this paper
• Liver abscess caused by Clostridium difficile.

  2001cited by this paper
• Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins.

  2001cited by this paper
• Fatal Pseudomembranous Colitis Associated with a Variant Clostridium difficile Strain Not Detected by Toxin A Immunoassay

  2001cited by this paper
• IgG Fc receptors.

  2001influential reference
• Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

  2001cited by this paper
• pH-Induced Conformational Changes inClostridium difficile Toxin B

  2000cited by this paper
• Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

  2000cited by this paper
• Clostridium difficile-associated diseases

  2000cited by this paper
• Endocytosis of FcgammaRI is regulated by two distinct signalling pathways.

  2000cited by this paper
• Endocytosis of FcγRI is regulated by two distinct signalling pathways

  2000cited by this paper
• Clostridium difficile colitis associated with chronic renal failure.

  1999cited by this paper
• Influence of the human high-affinity IgG receptor FcgammaRI (CD64) on residual infectivity of neutralized dengue virus.

  1999cited by this paper
• Pathogenesis of Clostridium difficile infection.

  1998cited by this paper
• Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling.

  1998cited by this paper
• The IgG Fc receptor family

  1998cited by this paper
• Science and pragmatism in the treatment and prevention of neutropenic infection.

  1998cited by this paper
• Clostridium difficile infection.

  1998cited by this paper
• A new multivalent B cell activation model--anti-IgD bound to Fc gamma RI: properties and comparison with CD40L-mediated activation.

  1997influential reference
• Role of resident mast cells and macrophages in the neutrophil migration induced by LTB4, fMLP and C5a des arg.

  1997cited by this paper
• Endocytosis.

  1997cited by this paper
• Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins.

  1996cited by this paper
• Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins

  1996cited by this paper
• Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A.

  1996cited by this paper
• Immune response to Clostridium difficile infection.

  1996cited by this paper
• Microbial recognition of target-cell glycoconjugates.

  1995cited by this paper
• Two distinct regions of FC gamma RI initiate separate signalling pathways involved in endocytosis and phagocytosis.

  1995cited by this paper
• Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters

  1995cited by this paper
• Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.

  1995cited by this paper
• Glucosylation of Rho proteins by Clostridium difficile toxin B

  1995cited by this paper
• Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit.

  1994cited by this paper
• Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin.

  1991cited by this paper
• Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B

  1991cited by this paper
• Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A

  1991cited by this paper
• Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y

  1991cited by this paper
• The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.

  1989cited by this paper
• Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction.

  1989cited by this paper
• The FC and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.

  1989cited by this paper
• Cellular internalisation of Clostridium difficile toxin A.

  1987cited by this paper
• Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin

  1987cited by this paper
• Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc

  1986cited by this paper
• Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B.

  1986cited by this paper
• Serum antibody response to toxins A and B of Clostridium difficile.

  1983cited by this paper
• Internalization of Clostridium difficile cytotoxin into cultured human lung fibroblasts.

  1983cited by this paper
• Purification and characterization of toxins A and B of Clostridium difficile

  1982cited by this paper

• Optimization of IgG1 immune complexes to stimulate cytokine production in innate cells.

  2025cites this paper
• Fit‐for‐purpose heterodivalent single‐domain antibody for gastrointestinal targeting of toxin B from Clostridium difficile

  2024cites this paper
• Antibody-dependent enhancement of toxicity of myotoxin II from Bothrops asper

  2024cites this paper
• Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective

  2022cites this paper
• Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection

  2022cites this paper
• Neutralizing epitopes on Clostridioides difficile toxin A revealed by the structures of two camelid VHH antibodies

  2022cites this paper
• Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy

  2021cites this paper
• AAV-mediated delivery of actoxumab and bezlotoxumab results in serum and mucosal antibody concentrations that provide protection from C. difficile toxin challenge

  2021cites this paper
• A probiotic yeast-based immunotherapy against Clostridioides difficile infection

  2020cites this paper
• Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters

  2018cites this paper
• Atorvastatin, losartan and captopril may upregulate IL‐22 in hypertension and coronary artery disease; the role of gene polymorphism

  2018cites this paper
• Novel Chimeric Protein Vaccines Against Clostridium difficile Infection

  2018cites this paper
• High-mobility group box 1 protein contributes to the immunogenicity of rTcdB-treated CT26 cells

  2018cites this paper
• Beyond binding: antibody effector functions in infectious diseases

  2017cites this paper
• Prospects from systems serology research

  2017cites this paper
• Salubrinal protects against Clostridium difficile toxin B-induced CT26 cell death

  2017cites this paper
• Identification of an Essential Region for Translocation of Clostridium difficile Toxin B

  2016cites this paper
• An update on antibody-based immunotherapies for Clostridium difficile infection

  2016cites this paper
• Intravenous adenovirus expressing a multi-specific, single-domain antibody neutralizing TcdA and TcdB protects mice from Clostridium difficile infection.

  2016cites this paper
• Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells.

  2015cites this paper
• Comparison of the protective effect of a commercially available western diamondback rattlesnake toxoid vaccine for dogs against envenomation of mice with western diamondback rattlesnake (Crotalus atrox), northern Pacific rattlesnake (Crotalus oreganus oreganus), and southern Pacific rattlesnake (Cro

  2015cites this paper
• Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.

  2015cites this paper
• Identification of Toxemia in Patients with Clostridium difficile Infection

  2015influential citation
• High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types

  2015cites this paper
• Antibodies for Treatment of Clostridium difficile Infection

  2014cites this paper
• A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.

  2014cites this paper
• Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.

  2013cites this paper
• A Segment of 97 Amino Acids within the Translocation Domain of Clostridium difficile Toxin B Is Essential for Toxicity

  2013cites this paper
• Antibody against TcdB, but not TcdA, prevents development of gastrointestinal and systemic Clostridium difficile disease.

  2013cites this paper
• A Chimeric Toxin Vaccine Protects against Primary and Recurrent Clostridium difficile Infection

  2012cites this paper
• Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models.

  2012cites this paper
• Low expression of FCGRIIB in macrophages of immune thrombocytopenia-affected individuals

  2012cites this paper
• An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivo.

  2012cites this paper
• , Infection Primary and Recurrent Clostridium difficile A Chimeric Toxin Vaccine Protects against

  2012cites this paper
• Medical Applications of Clostridia and Clostridial Toxins

  2012cites this paper
• B-cell epitope prediction for peptide-based vaccine design: towards a paradigm of biological outcomes for global health

  2011cites this paper
• Retargeting Clostridium difficile Toxin B to Neuronal Cells as a Potential Vehicle for Cytosolic Delivery of Therapeutic Biomolecules to Treat Botulism

  2011cites this paper
• Piglet models of acute or chronic Clostridium difficile illness.

  2010cites this paper
• Enhancement of IL-10 bioactivity using an IL-10 peptide-based vaccine exacerbates Leishmania major infection and improves airway inflammation in mice.

  2010cites this paper
• Méthodes de diagnostic de clostridium difficile et méthodes et vecteurs permettant l'expression de toxines recombinantes

  2009cites this paper
• An ultrasensitive rapid immunocytotoxicity assay for detecting Clostridium difficile toxins.

  2009cites this paper
• Monoclonal antibody-based therapies for microbial diseases

  2009cites this paper
• Clinical and Experimental Gastroenterology Dovepress

  year unknowncites this paper